The first step in Sanesco’s Communication System Management (CSM) model is Functional Assessment. Unlike the traditional test-and-treat diagnostic model, the CSM model uses serial testing to assess the function of the HP (hypothalamic-pituitary) and HPA (hypothalamic-pituitary-adrenal) axes. Serial testing allows the practitioner to monitor changes in a patient’s neuronal and hormonal responses over time.

The greatest benefit of this approach is that adjustments to the therapeutic protocol can be made throughout a patient’s treatment to ensure an optimal clinical outcome. An excellent adjunct to existing treatment protocols, the use of the CSM model can significantly enhance the recovery process and minimize the likelihood of symptom recurrence.

Sanesco currently offers six functional test profiles to determine imbalances in the function of the HP and the HPA axes:

When a patient presents one or more symptoms to the practitioner, they are given the appropriate Sanesco test kit(s) to establish baseline levels. Each non-invasive urine and/or saliva test provides a convenient, at-home collection method that encourages patient compliance.

The patient sends the collected sample(s) to Sanesco in a pre-addressed, postage-paid box. Test results are sent to Sanesco, whose expert team of multi-disciplinary researchers and cliniciansdevelops a recommended treatment protocol that takes into consideration the patient’s symptoms, the test results, and the collective wisdom of the team. A copy of the test results is then forwarded to the practitioner together with Sanesco’s individualized interpretation and educational comments. Whenever requested, Sanesco’s expert team is also available to further interpret test results and assist the practitioner in selecting a viable therapeutic approach.

A key advantage of Sanesco’s functional assessment protocol is testing frequency. After an Initial baseline is established, it is very important to regularly retest a patient’s neuronal and hormonal responses to measure changes that occur over time. Once therapy is initiated, the patient’s levels begin to shift; retesting allows the Restoration of a patient’s health, a period that may last from three to nine months, depending on the individual and the severity of their symptoms. When a patient’s symptoms are relieved and long-term health has been restored, annual or semi-annual testing is conducted to Maintain the patient’s state of health and prevent the return of symptoms.

Throughout the functional assessment period, the combined expertise of the multidisciplinary team is a distinct and significant benefit. Their knowledge and wisdom are the foundation of Sanesco’s CSM model and are reflected in the subsequent analysis and interpretation used to develop a recommended treatment protocol, including Sanesco’s Targeted Nutritional Therapy formulas.